Clinical_JJ review_NN :_: Hypertonic_JJ saline_JJ resuscitation_NN in_IN sepsis_NN Abstract_NP |_SYM The_DT present_JJ review_NN discusses_VBZ the_DT hemodynamic_JJ effects_NNS of_IN hypertonic_JJ saline_NN in_IN experimental_JJ shock_NN and_CC in_IN patients_NNS with_IN sepsis_NN ._SENT We_PP comment_VB on_IN the_DT mechanisms_NNS of_IN action_NN of_IN hypertonic_JJ saline_NN ,_, calling_VBG upon_IN data_NNS in_IN hemorrhagic_JJ and_CC septic_JJ shock_NN ._SENT Specific_JJ actions_NNS of_IN hypertonic_JJ saline_NN in_IN severe_JJ sepsis_NN and_CC septic_JJ shock_NN are_VBP highlighted_VBN ._SENT Data_NNS are_VBP available_JJ that_IN support_NN potential_JJ benefits_NNS of_IN hypertonic_JJ saline_JJ infusion_NN in_IN various_JJ aspects_NNS of_IN the_DT pathophysiology_NN of_IN sepsis_NN ,_, including_VBG tissue_NN hypoperfusion_NN ,_, decreased_VBD oxygen_NN consumption_NN ,_, endothelial_JJ dysfunction_NN ,_, cardiac_JJ depression_NN ,_, and_CC the_DT presence_NN of_IN a_DT broad_JJ array_NN of_IN proinflammatory_JJ cytokines_NNS and_CC various_JJ oxidant_NN species_NNS ._SENT The_DT goal_NN of_IN research_NN in_IN this_DT field_NN is_VBZ to_TO identify_VB reliable_JJ therapies_NNS to_TO prevent_VB ischemia_NN and_CC inflammation_NN ,_, and_CC to_TO reduce_VB mortality_NN ._SENT hemorrhagic_JJ ,_, hypertonic_JJ saline_NN ,_, inflammation_NN ,_, sepsis_NN ,_, shock_NN ,_, The_DT incidence_NN of_IN septic_JJ shock_NN has_VBZ increased_VBN during_IN the_DT past_JJ several_JJ decades_NNS ,_, whereas_IN mortality_NN rates_NNS have_VBP remained_VBN constant_JJ or_CC have_VBP decreased_VBN slightly_RB ._SENT Septic_JJ shock_NN is_VBZ associated_VBN with_IN high_JJ mortality_NN rates_NNS of_IN 30_CD --_: 80_CD %_NN ._SENT Sepsis_NN presents_NNS with_IN a_DT systemic_JJ inflammatory_JJ response_NN ,_, peripheral_JJ vasodilatation_NN ,_, myocardial_JJ depression_NN ,_, intravascular_JJ volume_NN depression_NN ,_, and_CC increased_VBD metabolism_NN ._SENT Despite_IN considerable_JJ knowledge_NN of_IN the_DT pathophysiology_NN of_IN the_DT systemic_JJ inflammatory_JJ response_NN syndrome_NN ,_, clinical_JJ trials_NNS using_VBG interventions_NNS such_JJ as_IN immunotherapy_NN have_VBP yielded_VBN negative_JJ results_NNS ._SENT Global_JJ tissue_NN hypoxia_NN results_NNS in_IN an_DT imbalance_NN between_IN systemic_JJ oxygen_NN delivery_NN and_CC demand_NN ,_, and_CC is_VBZ a_DT key_JJ development_NN preceding_VBG multiple_JJ organ_NN failure_NN and_CC death_NN ._SENT Rivers_NNS and_CC colleagues_NNS demonstrated_VBD the_DT importance_NN of_IN goal-directed_JJ therapy_NN in_IN septic_JJ shock_NN and_CC severe_JJ sepsis_NN ._SENT An_DT early_JJ resuscitation_NN strategy_NN ,_, which_WDT was_VBD goal_NN oriented_VBN with_IN respect_NN to_TO manipulation_NN of_IN cardiac_JJ preload_NN ,_, afterload_NN and_CC contractility_NN ,_, reduced_VBD the_DT incidence_NN of_IN multiple_JJ organ_NN dysfunction_NN and_CC mortality_NN ._SENT Hemodynamic_JJ management_NN in_IN severe_JJ sepsis_NN and_CC septic_JJ shock_NN includes_VBZ rapid_JJ restoration_NN of_IN intravascular_JJ volume_NN and_CC adequate_JJ balance_NN between_IN systemic_JJ oxygen_NN delivery_NN and_CC demand_NN ._SENT Several_JJ liters_NNS of_IN fluids_NNS (_( crystalloids_NNS or_CC colloids_NNS )_) are_VBP usually_RB necessary_JJ to_TO normalize_VB preload_NN and_CC filling_VBG pressures_NNS ,_, with_IN the_DT objective_NN of_IN establishing_VBG adequate_JJ tissue_NN perfusion_NN and_CC oxygen_NN delivery_NN ._SENT The_DT infusion_NN of_IN several_JJ liters_NNS of_IN fluid_NN is_VBZ associated_VBN with_IN the_DT adverse_JJ effect_NN of_IN extravasation_NN into_IN the_DT interstitial_JJ space_NN ._SENT In_IN sepsis_NN in_IN particular_JJ ,_, this_DT may_MD result_VB in_IN pulmonary_JJ edema_NN ._SENT Nevertheless_RB ,_, adequate_JJ volume_NN repletion_NN with_IN hemodynamic_JJ normalization_NN may_MD not_RB be_VB sufficient_JJ to_TO prevent_VB persistent_JJ microcirculatory_JJ dysfunction_NN ,_, which_WDT may_MD cause_VB ischemia_NN and_CC tissue_NN damage_NN ._SENT The_DT observation_NN reported_VBD by_IN Velasco_NP and_CC colleagues_NNS in_IN 1980_CD of_IN beneficial_JJ effects_NNS of_IN 7.5_CD %_NN saline_JJ solutions_NNS in_IN dogs_NNS with_IN severe_JJ hemorrhagic_JJ shock_NN attracted_VBD interest_NN to_TO this_DT field_NN ._SENT The_DT short_JJ duration_NN of_IN the_DT circulatory_JJ effects_NNS of_IN hypertonic_JJ saline_JJ solution_NN (_( HSS_NP )_) has_VBZ been_VBN attributed_VBN to_TO a_DT rapid_JJ equilibrium_NN of_IN the_DT hyperosmotic_JJ solute_NN between_IN extracellular_JJ and_CC intra-cellular_JJ compartments_NNS ._SENT Therefore_RB ,_, HSS_NP has_VBZ been_VBN combined_VBN with_IN colloids_NNS (_( i.e._FW dextran_NN or_CC hetastarch_NN )_) in_IN order_NN to_TO achieve_VB a_DT longer_RBR intravascular_JJ effect_NN ._SENT This_DT combination_NN has_VBZ synergistic_JJ effects_NNS ,_, by_IN increasing_VBG plasma_NN osmolarity_NN and_CC osmotic_JJ pressure_NN ._SENT Since_IN the_DT 1980s_NNS ,_, several_JJ studies_NNS have_VBP been_VBN performed_VBN that_WDT used_VBD small_JJ volume_NN resuscitation_NN ,_, which_WDT is_VBZ defined_VBN as_IN a_DT rapid_JJ infusion_NN of_IN HSS_NP (_( NaCl_NP 7.2_CD --_: 7.5_CD %_NN )_) ,_, in_IN combination_NN with_IN dextran_NN or_CC hetastarch_NN ,_, at_IN a_DT dose_NN of_IN 4_CD ml/kg_NN into_IN a_DT peripheral_JJ vein_NN ._SENT Recent_JJ studies_NNS have_VBP used_VBN HSS_NP in_IN the_DT treatment_NN of_IN sepsis_NN and_CC have_VBP demonstrated_VBN some_DT promising_JJ beneficial_JJ effects_NNS ._SENT There_EX is_VBZ a_DT decreased_VBN susceptibility_NN to_TO sepsis_NN following_VBG administration_NN of_IN HSS_NP in_IN hemorrhagic_JJ shock_NN ._SENT After_IN 24_CD hours_NNS of_IN cecal_JJ ligation_NN and_CC perforation_NN ,_, animals_NNS that_WDT received_VBD HSS_NP had_VBD fewer_JJR bacteria_NNS in_IN serum_NN ,_, lower_JJR formation_NN of_IN abscesses_NNS in_IN liver_NN and_CC lungs_NNS ,_, and_CC less_RBR pulmonary_JJ and_CC hepatic_JJ injury_NN ._SENT Reduced_VBN organ_NN injury_NN in_IN the_DT HSS_NP group_NN might_MD have_VB been_VBN related_VBN to_TO an_DT improved_VBN hemodynamic_JJ profile_NN and_CC decreased_VBD extrapulmonary_JJ volume_NN ._SENT Also_RB ,_, effects_NNS on_IN microcirculation_NN (_( i.e._FW reduction_NN in_IN ischemia_NN and_CC effects_NNS related_VBN to_TO immune_JJ function_NN )_) might_MD have_VB contributed_VBN partly_RB to_TO decreased_VBN organ_NN injury_NN ._SENT Experimental_JJ studies_NNS in_IN septic_JJ shock_NN have_VBP shown_VBN beneficial_JJ effects_NNS similar_JJ to_TO those_DT reported_VBN in_IN studies_NNS of_IN hemorrhagic_JJ shock_NN ._SENT Studies_NNS of_IN HSS_NP alone_RB or_CC combined_VBN with_IN het-astarch_NN in_IN sepsis_NN demonstrated_VBN hemodynamic_JJ improvements_NNS ,_, but_CC these_DT effects_NNS had_VBD a_DT short_JJ period_NN of_IN action_NN ._SENT However_RB ,_, these_DT findings_NNS bring_VBP new_JJ possibilities_NNS to_TO treatment_NN of_IN septic_JJ patients_NNS ,_, if_IN the_DT treatments_NNS are_VBP instituted_VBN early_RB in_IN course_NN of_IN the_DT disease_NN ._SENT Hemodynamic_JJ resuscitation_NN per_IN se_FW can_MD reduce_VB the_DT inflammatory_JJ response_NN in_IN sepsis_NN ,_, reducing_VBG the_DT phenomenon_NN of_IN ischemia/reperfusion_NN ._SENT On_IN the_DT other_JJ hand_NN ,_, several_JJ studies_NNS have_VBP demonstrated_VBN that_IN HSS_NP modulates_VBZ immune_JJ function_NN favorably_RB (_( i.e._FW by_IN reducing_VBG production_NN and_CC release_NN of_IN proinflammatory_JJ cytokines_NNS and_CC augmenting_VBG interleukin-10_JJ induction_NN ;_: by_IN reducing_VBG L-selectin_NP expression_NN in_IN neutrophils_NNS ;_: and_CC by_IN reducing_VBG the_DT oxidative_JJ burst_NN )_) ._SENT Together_RB ,_, those_DT studies_NNS indicate_VBP that_IN HSS_NP has_VBZ actions_NNS in_IN two_CD important_JJ aspects_NNS of_IN septic_JJ shock_NN :_: hemodynamics_NNS and_CC immunomodula-tion_NN ._SENT Notwithstanding_IN the_DT recent_JJ intense_JJ focus_NN on_IN immunomodulation_NN in_IN sepsis_NN ,_, Rivers_NP and_CC colleagues_NNS showed_VBD that_IN early_RB hemodynamically_RB centered_VBN therapy_NN yielded_VBD significant_JJ benefits_NNS with_IN respect_NN to_TO outcome_NN ._SENT Observations_NNS from_IN several_JJ experimental_JJ studies_NNS suggest_VBP that_IN HSS_NP combined_VBN with_IN a_DT colloid_JJ solution_NN is_VBZ able_JJ to_TO improve_VB macrocirculation_NN in_IN sepsis_NN ._SENT Also_RB ,_, HSS_NP prevented_VBD vascular_JJ dysfunction_NN and_CC restored_VBN microcirculatory_JJ blood_NN flow_NN by_IN capillary_JJ reopening_VBG ._SENT This_DT effect_NN resulted_VBD in_IN a_DT beneficial_JJ redistribution_NN of_IN regional_JJ blood_NN flow_NN to_TO heart_NN ,_, kidney_NN ,_, and_CC splanchnic_JJ organs_NNS ._SENT The_DT first_JJ clinical_JJ study_NN to_TO evaluate_VB the_DT effects_NNS of_IN small_JJ volume_NN resuscitation_NN in_IN severe_JJ sepsis_NN was_VBD conducted_VBN by_IN Hannemann_NP and_CC colleagues_NNS ._SENT Those_DT authors_NNS observed_VBD increased_VBN oxygen_NN transport_NN ,_, cardiac_JJ output_NN ,_, and_CC pulmonary_JJ capillary_JJ wedge_NN pressure_NN in_IN patients_NNS treated_VBN with_IN HSS_NP ._SENT Except_IN for_IN the_DT increase_NN in_IN pulmonary_JJ capillary_JJ wedge_NN pressure_NN ,_, none_NN of_IN the_DT cardiovascular_JJ changes_NNS lasted_VBN for_IN longer_JJR than_IN 60_CD min_NN ._SENT Plasma_NN sodium_NN levels_NNS increased_VBN and_CC normalized_VBN within_IN 24_CD hours_NNS after_IN HSS_NP infusion_NN ._SENT Oliveira_NP and_CC colleagues_NNS studied_VBD the_DT hemodynamic_JJ effects_NNS of_IN a_DT hypertonic_JJ saline/dextran_NN solution_NN as_IN compared_VBN with_IN those_DT of_IN a_DT normal_JJ saline_JJ solution_NN in_IN severe_JJ sepsis_NN ._SENT Patients_NNS were_VBD randomly_RB assigned_VBN ,_, in_IN a_DT blinded_VBN manner_NN ,_, to_TO receive_VB 250_CD ml_NN of_IN a_DT solution_NN of_IN either_DT normal_JJ saline_NN (_( n_NN =_SYM 16_CD )_) or_CC hypertonic_JJ saline_NN (_( NaCl_NP 7.5%/dextran_NP 8_CD %_NN ;_: n_NN =_SYM 13_CD )_) ._SENT Before_IN they_PP received_VBD normal_JJ saline_NN or_CC HSS_NP ,_, patients_NNS had_VBD to_TO have_VB been_VBN stable_NN (_( i.e._FW no_DT requirement_NN for_IN vasoactive_JJ drug_NN or_CC volume_NN change_NN )_) for_IN at_IN least_JJS 60_CD min_NN ._SENT Over_IN the_DT 180_CD min_NN following_VBG infusion_NN of_IN normal_JJ saline_NN or_CC HSS_NP (_( i.e._FW the_DT period_NN of_IN study_NN )_) ,_, the_DT rate_NN of_IN infusion_NN of_IN regular_JJ fluid_NN or_CC vasoactive_JJ drug_NN was_VBD not_RB changed_VBN ._SENT The_DT cardiac_NN and_CC stroke_NN volume_NN indices_NN increased_VBD ,_, and_CC systemic_JJ vascular_JJ resistance_NN decreased_VBD only_RB in_IN the_DT HSS_NP group_NN ,_, without_IN any_DT change_NN in_IN arterial_JJ pressure_NN ._SENT The_DT increase_NN in_IN plasma_NN sodium_NN levels_NNS lasted_VBD for_IN 6_CD hours_NNS in_IN the_DT HSS_NP group_NN ._SENT Those_DT investigators_NNS concluded_VBD that_IN hypertonic_JJ saline/dextran_JJ solution_NN improved_VBD cardiovascular_JJ performance_NN and_CC resuscitated_VBD severely_RB septic_JJ patients_NNS through_IN a_DT volume_NN effect_NN ,_, but_CC may_MD also_RB directly_RB improve_VB cardiac_JJ function_NN ._SENT The_DT main_JJ proposed_VBN mechanisms_NNS of_IN action_NN of_IN HSS_NP are_VBP as_RB follows_VBZ :_: instantaneous_JJ mobilization_NN of_IN fluids_NNS from_IN intracellular_JJ to_TO extracellular_JJ compartments_NNS by_IN the_DT osmotic_JJ gradient_NN produced_VBN by_IN HSS_NP ;_: increased_VBD myocardial_JJ contractility_NN ;_: reduced_VBN endothelial_JJ and_CC tissue_NN edema_NN ,_, improving_VBG microcirculation_NN ;_: improved_VBN blood_NN viscosity_NN due_JJ to_TO hemodi-lution_NN ;_: and_CC immunomodulation_NN ._SENT Intravascular_JJ volume_NN expansion_NN |_SYM A_DT rapid_JJ increase_NN in_IN mean_JJ arterial_JJ pressure_NN occurs_VBZ following_VBG HSS_NP infusion_NN ._SENT Studies_NNS have_VBP shown_VBN a_DT redistribution_NN of_IN fluids_NNS from_IN the_DT perivascular_NN to_TO the_DT intravascular_JJ space_NN ,_, and_CC consequent_JJ plasma_NN expansion_NN ._SENT The_DT hemodynamic_JJ effects_NNS of_IN HSS_NP infusion_NN have_VBP been_VBN studied_VBN in_IN sepsis_NN ._SENT Most_JJS of_IN the_DT studies_NNS found_VBD that_IN HSS_NP infusion_NN caused_VBD a_DT rapid_JJ and_CC significant_JJ increase_NN in_IN oxygen_NN delivery_NN ,_, and_CC elevated_JJ cardiac_JJ output_NN and_CC increased_VBN oxygen_NN extraction_NN ,_, but_CC these_DT effects_NNS were_VBD transient_JJ ._SENT Therefore_RB ,_, despite_IN the_DT immunologic_JJ background_NN of_IN sepsis_NN and_CC the_DT significant_JJ role_NN played_VBN by_IN immunologic_JJ mechanisms_NNS in_IN the_DT disease_NN ,_, hemodynamic_JJ resuscitation_NN has_VBZ also_RB proved_VBN important_JJ in_IN management_NN of_IN sepsis_NN ._SENT HSS_NP may_MD be_VB able_JJ to_TO resuscitate_VB septic_JJ patients_NNS better_RBR and_CC more_RBR rapidly_RB ,_, during_IN the_DT critical_JJ '_POS golden_JJ hours_NNS '_'' of_IN the_DT disease_NN ._SENT Cardiac_JJ contractility_NN effects_NNS |_SYM Improvement_NP in_IN myocardial_JJ contractility_NN may_MD be_VB related_VBN to_TO a_DT direct_JJ hyperosmolar_NN effect_NN ,_, restoring_VBG transmembrane_NN potentials_NNS or_CC decreasing_VBG myocardial_JJ edema_NN ._SENT Reported_JJ findings_NNS indicate_VBP that_IN ventricular_JJ contractile_JJ force_NN is_VBZ enhanced_VBN by_IN moderate_JJ degrees_NNS of_IN hyperosmolarity_NN and_CC is_VBZ depressed_VBN by_IN severe_JJ hyperosmolarity_NN both_CC in_IN vivo_JJ and_CC in_IN vitro_NN ._SENT HSS_NP has_VBZ been_VBN shown_VBN to_TO increase_VB left_JJ ventricular_JJ dP/dtmax_NN ,_, cardiac_JJ output_NN ,_, and_CC stroke_NN work_NN at_IN equivalent_NN or_CC lower_JJR atrial_JJ filling_VBG pressures_NNS than_IN with_IN isotonic_JJ solutions_NNS ._SENT Myocardial_JJ function_NN is_VBZ depressed_VBN even_RB in_IN the_DT early_JJ hyperdynamic_JJ phase_NN of_IN sepsis_NN ._SENT However_RB ,_, hypertonic_JJ solutions_NNS have_VBP been_VBN shown_VBN to_TO improve_VB contractility_NN in_IN animal_NN and_CC human_JJ studies_NNS of_IN sepsis_NN ._SENT These_DT improvements_NNS in_IN myocardial_JJ performance_NN were_VBD unrelated_JJ to_TO changes_NNS in_IN coronary_JJ flow_NN or_CC myocardial_JJ oxygen_NN consumption_NN ._SENT Neural_JJ effect_NN :_: the_DT role_NN of_IN lung_NN innervation_NN |_SYM Two_NP forms_NNS of_IN experimental_JJ evidence_NN indicate_VBP that_IN a_DT pulmonary_JJ reflex_JJ mechanism_NN may_MD participate_VB in_IN the_DT resuscitative_JJ effects_NNS of_IN hypertonic_JJ saline_NN ._SENT First_RB ,_, it_PP has_VBZ been_VBN suggested_VBN that_DT passage_NN of_IN hypertonic_JJ saline_NN through_IN the_DT pulmonary_JJ circulation_NN is_VBZ necessary_JJ for_IN resuscitation_NN ._SENT In_IN dogs_NNS ,_, prepulmonary_JJ (_( right_RB atrial_JJ ,_, pulmonary_JJ arterial_JJ )_) administration_NN resulted_VBN in_IN resuscitation_NN ,_, but_CC postpulmonary_JJ (_( left_RB atrial_JJ ,_, aortic_JJ )_) administration_NN did_VBD not_RB provide_VB effective_JJ resuscitation_NN ._SENT However_RB ,_, data_NNS from_IN sheep_NN suggested_VBD that_IN the_DT site_NN of_IN administration_NN has_VBZ no_DT influence_NN on_IN the_DT resuscitative_JJ effects_NNS of_IN hypertonic_JJ saline_NN ._SENT The_DT differences_NNS between_IN the_DT reports_NNS may_MD be_VB explained_VBN by_IN the_DT different_JJ species_NN investigated_VBD ._SENT The_DT second_JJ form_NN of_IN evidence_NN for_IN lung_NN innervation_NN is_VBZ provided_VBN by_IN studies_NNS indicating_VBG that_DT vagal_JJ blockade_NN attenuates_VBZ the_DT hemodynamic_JJ response_NN to_TO hypertonic_JJ saline_JJ administration_NN in_IN hypovolemic_JJ dogs_NNS ._SENT In_IN contrast_NN to_TO this_DT finding_NN ,_, nearly_RB identical_JJ improvements_NNS in_IN mean_JJ arterial_JJ pressure_NN ,_, cardiac_JJ output_NN ,_, heart_NN rate_NN ,_, and_CC blood_NN chemistry_NN parameters_NNS in_IN response_NN to_TO administration_NN of_IN hypertonic_JJ saline_NN into_IN innervated_VBN and_CC denervated_VBN pulmonary_JJ circulations_NNS were_VBD reported_VBN ._SENT However_RB ,_, Younes_NP and_CC coworkers_NNS conducted_VBD studies_NNS 7_CD days_NNS after_IN surgery_NN in_IN a_DT model_NN of_IN total_JJ lung_NN denervation_NN ._SENT In_IN that_DT model_NN ,_, HSS_NP administration_NN produced_VBD a_DT sustained_JJ hemodynamic_JJ improvement_NN in_IN the_DT innervated_VBN group_NN as_IN compared_VBN with_IN the_DT denervated_JJ group_NN ._SENT The_DT different_JJ preparations_NNS may_MD explain_VB those_DT contrasting_VBG results_NNS ._SENT Endothelial_JJ effects_NNS |_SYM In_IN the_DT initial_JJ phase_NN of_IN hypovolemia_NN and_CC shock_NN ,_, the_DT hypoxia_NN and_CC activation_NN of_IN polymorphonuclear_JJ cells_NNS in_IN the_DT endothelium_NN of_IN postcapillary_JJ venules_NNS produce_VBP endothelial_JJ cell_NN edema_NN ._SENT This_DT leads_VBZ to_TO capillary_JJ lumen_NN narrowing_NN ,_, which_WDT can_MD cause_VB complete_JJ obstruction_NN of_IN local_JJ blood_NN flow_NN and_CC reduction_NN in_IN oxygen_NN transport_NN ._SENT During_IN small_JJ volume_NN resuscitation_NN ,_, the_DT intracellular_JJ fluid_NN is_VBZ primarily_RB mobilized_VBN from_IN microvascular_JJ endothelial_JJ cells_NNS and_CC erythrocytes_NNS ._SENT This_DT effect_NN is_VBZ more_RBR pronounced_VBN in_IN capillaries_NNS in_IN which_WDT edema_NN is_VBZ greater_JJR ._SENT It_PP produces_VBZ a_DT reduction_NN in_IN hydraulic_JJ resistance_NN and_CC an_DT improvement_NN in_IN tissue_NN perfusion_NN ._SENT It_PP has_VBZ been_VBN demonstrated_VBN that_IN a_DT reduction_NN in_IN endothelial_JJ volume_NN of_IN 20_CD %_NN after_IN infusion_NN of_IN HSS/dextran_NP ,_, as_RB well_RB as_IN an_DT increase_NN in_IN sinusoidal_JJ perfusion_NN ,_, may_MD occur_VB ,_, resulting_VBG in_IN significant_JJ improvements_NNS in_IN hepatic_JJ energetic_JJ status_NN and_CC excretory_JJ function_NN ._SENT Vasoactive_JJ mediators_NNS |_SYM Studies_NNS have_VBP revealed_VBN increased_VBN cardiac_JJ output_NN and_CC restoration_NN of_IN peripheral_JJ blood_NN flow_NN mediated_VBN by_IN vasodilating_VBG substances_NNS released_VBN after_IN HSS_NP infusion_NN ,_, especially_RB prostacycline_NN ,_, together_RB with_IN an_DT increase_NN in_IN the_DT 6-cheto-prostaglandin_JJ F1alpha_NP :thromboxane_NN B2_NN ratio_NN ._SENT The_DT decrease_NN in_IN total_JJ peripheral_JJ resistance_NN is_VBZ the_DT main_JJ factor_NN responsible_JJ for_IN the_DT hypotension_NN that_WDT occurs_VBZ immediately_RB after_IN infusion_NN of_IN HSS_NP ._SENT The_DT neuroendocrine_NN response_NN to_TO 7.5_CD %_NN HSS/dextran_NP after_IN hemorrhagic_JJ shock_NN was_VBD quantified_VBN in_IN pigs_NNS ._SENT The_DT result_NN of_IN hemodilution_NN in_IN association_NN with_IN plasma_NN volume_NN expansion_NN was_VBD decreased_VBN plasma_NN levels_NNS of_IN adrenocorticotropic_JJ hormone_NN ,_, cortisol_NN ,_, and_CC aldosterone_NN ._SENT Also_RB ,_, reductions_NNS in_IN plasma_NN concentrations_NNS of_IN norepinephrine_NN (_( noradrenaline_NN )_) ,_, epinephrine_NN (_( adrenaline_NN )_) ,_, lysine_NN ,_, vasopressin_NN ,_, and_CC renin_NN were_VBD greater_JJR with_IN hemodilution_NN combined_VBN with_IN plasma_NN volume_NN expansion_NN than_IN with_IN hemodilution_NN alone_RB ,_, indicating_VBG that_IN alterations_NNS in_IN hormone_NN release_NN have_VBP a_DT role_NN to_TO play_VB in_IN cardiovascular_JJ response_NN in_IN this_DT model_NN of_IN resuscitation_NN ._SENT Immunomodulatory_JJ effects_NNS |_SYM Hemorrhage_NN and_CC sepsis_NN often_RB initiate_VB a_DT systemic_JJ inflammatory_JJ response_NN that_WDT is_VBZ accompanied_VBN by_IN organ_NN dysfunction_NN ,_, most_RBS commonly_RB acute_JJ lung_NN injury_NN ._SENT Neutrophil_JJ sequestration_NN in_IN the_DT lung_NN is_VBZ a_DT necessary_JJ prerequisite_NN for_IN development_NN of_IN lung_NN injury_NN in_IN most_JJS models_NNS of_IN hemorrhagic_JJ and_CC septic_JJ shock_NN ._SENT Ischemia_NN has_VBZ been_VBN shown_VBN to_TO lead_VB to_TO accumulation_NN of_IN neutrophils_NNS and_CC other_JJ leukocytes_NNS in_IN the_DT microvascular_JJ bed_NN of_IN many_JJ organs_NNS ._SENT HSS_NP has_VBZ been_VBN shown_VBN to_TO reduce_VB lung_NN injury_NN after_IN hemorrhagic_JJ shock_NN ._SENT Those_DT studies_NNS showed_VBD that_IN HSS_NP produced_VBD the_DT following_VBG improvements_NNS in_IN the_DT lung_NN :_: reduction_NN in_IN neutrophil_JJ accumulation_NN ,_, less_JJR neutrophils_NNS recovered_VBN on_IN bonchealveolar_JJ lavage_NN ,_, reduced_VBN albumin_NN leak_NN and_CC a_DT lower_JJR degree_NN of_IN histopathologic_JJ injury_NN ._SENT The_DT mechanism_NN of_IN neutrophil_JJ sequestration_NN or_CC adhesion_NN depends_VBZ on_IN the_DT particular_JJ inflammatory_JJ condition_NN ._SENT The_DT CD11b_NP integrin_NN is_VBZ a_DT vital_JJ component_NN of_IN neutrophil_NN --_: endothelial_JJ interactions_NNS ,_, and_CC in_IN this_DT respect_NN Rizoli_NP and_CC colleagues_NNS showed_VBD that_IN HSS_NP prevented_VBD lipopolysaccharide-stimulated_JJ expression_NN and_CC activation_NN of_IN CD11b_NP ._SENT Corroborating_VBG those_DT data_NNS ,_, HSS_NP has_VBZ been_VBN shown_VBN to_TO decrease_VB neutrophil_JJ L-selectin_NP expression_NN and_CC to_TO eliminate_VB neutrophil_JJ priming_NN by_IN mesenteric_JJ lymph_NN production_NN ;_: this_DT suggests_VBZ that_IN HSS_NP reduces_VBZ lung_NN injury_NN by_IN preventing_VBG neutrophil_JJ adhesion_NN to_TO endothelium_NN ._SENT Also_RB ,_, Oreopoulos_NP and_CC colleagues_NNS showed_VBD inhibition_NN of_IN ischemia/reperfusion-induced_JJ hepatic_JJ expression_NN of_IN intercellular_JJ adhesion_NN molecule-1_JJ mRNA_NN with_IN HSS_NP as_IN compared_VBN with_IN normal_JJ saline_NN ._SENT Studies_NNS into_IN the_DT action_NN of_IN HSS_NP on_IN cellular_JJ mechanisms_NNS have_VBP yielded_VBN data_NNS that_WDT indicate_VBP that_IN HSS_NP regulates_VBZ the_DT expression_NN and_CC release_NN of_IN elastase_NN ,_, cytokines_NNS ,_, free_JJ radicals_NNS ,_, and_CC adhesion_NN molecules_NNS ._SENT T_NN cells_NNS incubated_VBN at_IN NaCl_NP levels_NNS of_IN up_IN to_TO 180_CD mmol/l_NN exhibited_VBD 100_CD %_NN enhancement_NN of_IN proliferation_NN (_( these_DT concentrations_NNS of_IN salt_NN are_VBP similar_JJ to_TO the_DT plasma_NN sodium_NN levels_NNS that_WDT are_VBP introduced_VBN by_IN the_DT traditional_JJ dose_NN of_IN 4_CD ml/kg_NN of_IN a_DT 7.5_CD %_NN NaCl_NP solution_NN )_) ._SENT Several_JJ circulating_VBG factors_NNS with_IN T-cell_NN suppressive_JJ activity_NN have_VBP been_VBN identified_VBN in_IN trauma_NN patients_NNS ,_, suggesting_VBG that_IN these_DT factors_NNS cause_VBP a_DT down-regulation_NN of_IN T-cell_NN function_NN after_IN trauma_NN ._SENT Prostaglandin_NN E2_NN is_VBZ a_DT T-cell_NN suppressor_NN that_WDT interferes_VBZ with_IN calcineurin-dependent_JJ signaling_VBG pathways_NNS ,_, and_CC thereby_RB inhibits_VBZ interleukin-2_JJ production_NN and_CC T-cell_NN proliferation_NN ._SENT Human_JJ peripheral_JJ blood_NN mononuclear_JJ cells_NNS were_VBD suppressed_VBN when_WRB incubated_VBN with_IN prostaglandin_NN E2_NN ._SENT T-cell_NN proliferation_NN was_VBD significantly_RB enhanced_VBN when_WRB the_DT cells_NNS were_VBD exposed_VBN to_TO HSS_NP ._SENT Cell-mediated_JJ immune_JJ function_NN and_CC splenocyte_NN proliferation_NN is_VBZ significantly_RB suppressed_VBN after_IN hemorrhage_NN ,_, and_CC HSS_NP resuscitation_NN clearly_RB restored_VBN splenocyte_NN function_NN and_CC cell-mediated_JJ immune_JJ function_NN ._SENT Hypertonic_JJ saline_NN modulates_VBZ cellular_JJ signaling_VBG pathways_NNS |_SYM Most_JJS knowledge_NN in_IN this_DT area_NN stems_VBZ from_IN work_NN with_IN Saccharomyces_NP cerevisiae_NNS ._SENT Hyperosmotic_JJ conditions_NNS trigger_VBP activation_NN of_IN a_DT mitogen-activated_JJ protein_NN kinase_NN (_( MAPK_NP )_) termed_VBD high-osmolarity_NN glycerol_NN response_NN (HOG)1_NN in_IN yeast_NN cells_NNS ._SENT Han_NP and_CC colleagues_NNS identified_VBD a_DT mammalian_JJ equivalent_NN of_IN HOG1_NP in_IN monocytic_JJ cells_NNS ._SENT This_DT protein_NN ,_, namely_RB MAPK_NP p38_NN ,_, shares_NNS approximately_RB 60_CD %_NN amino_NN acid_JJ sequence_NN with_IN HOG1_NP ._SENT MAPK_NP p38_NP is_VBZ tyrosine_NN phosphorylated_JJ and_CC activated_VBN under_IN hypertonic_JJ conditions_NNS ,_, suggesting_VBG the_DT existence_NN of_IN an_DT osmolarity_NN sensing_VBG system_NN in_IN mammalian_JJ cells_NNS ._SENT A_DT human_JJ T-cell_NN line_NN (_( Jurkat_NP cells_NNS )_) was_VBD used_VBN to_TO investigate_VB whether_IN HSS_NP triggers_VBZ signaling_VBG events_NNS through_IN protein_NN phosphorylation_NN ._SENT HSS_NP exposure_NN permitted_VBD tyrosine_NN phosphorylation_NN of_IN cellular_JJ protein_NN in_IN a_DT dose-dependent_JJ manner_NN ._SENT Sepsis_NN ,_, trauma_NN ,_, and_CC hemorrhage_NN activate_VBP neutrophils_NNS and_CC can_MD trigger_VB excessive_JJ release_NN of_IN cytotoxic_JJ mediators_NNS ,_, damaging_VBG host_NN tissues_NNS and_CC resulting_VBG in_IN major_JJ post-traumatic_JJ complications_NNS ._SENT Clinically_RB relevant_JJ hypertonicity_NN suppressed_VBD degranulation_NN and_CC superoxide_NN formation_NN in_IN response_NN to_TO N-formyl-methionyl-leucyl-phenylalanine_NP (_( fMLP_NN )_) ,_, and_CC blocked_VBD the_DT activation_NN of_IN the_DT MAPKs_NP ERK_NP 1/2_CD and_CC p38_NN ._SENT HSS_NP did_VBD not_RB suppress_VB neutrophil_JJ oxidative_JJ burst_NN in_IN response_NN to_TO phorbol_NN myris-tate_NN acetate_NN ._SENT This_DT indicates_VBZ that_IN HSS_NP suppresses_VBZ neutrophil_JJ function_NN by_IN intercepting_VBG signal_NN pathways_NNS upstream_JJ of_IN or_CC apart_RB from_IN protein_NN kinase_NN C._NP Neutrophils_NP incubated_VBD in_IN hypertonic_JJ saline_NN showed_VBD a_DT reduction_NN in_IN platelet-activating_VBG factor_NN mediated_VBN MAPK_NP p38_NN signal_NN transduction_NN ._SENT Clinically_RB relevant_JJ levels_NNS of_IN hypertonic_JJ saline_JJ attenuated_JJ platelet-activating_NN factor_NN mediated_VBD beta2_JJ integrin_NN expression_NN ,_, superoxide_NN radical_JJ production_NN ,_, and_CC elastase_NN release_NN ._SENT Recent_JJ evidence_NN suggests_VBZ that_IN cytoskeletal_JJ reorganization_NN is_VBZ critical_JJ for_IN receptor-mediated_JJ signal_NN transduction_NN ._SENT Cytoskeletal_JJ disruption_NN prevented_VBD attenuation_NN of_IN receptor-mediated_JJ MAPK_NP p38_NN activation_NN by_IN hypertonic_JJ saline_NN ._SENT Therefore_RB ,_, hypertonic_JJ saline_NN alters_VBZ cell_NN shape_NN ,_, and_CC this_DT is_VBZ followed_VBN by_IN cytoskeletal_JJ reorganization_NN with_IN a_DT resultant_JJ immunomodulatory_JJ effect_NN ._SENT Data_NNS have_VBP been_VBN reported_VBN that_WDT indicate_VBP that_IN HSS_NP augments_VBZ interleukin-10_JJ induction_NN by_IN lipopolysaccharide_NN at_IN the_DT gene_NN level_NN and_CC reduces_VBZ tumor_NN necrosis_NN factor_NN levels_NNS ,_, independent_JJ of_IN nuclear_JJ factor-kappaB_NN signaling_VBG ._SENT These_DT actions_NNS may_MD explain_VB the_DT lesser_JJR degree_NN of_IN injury_NN following_VBG HSS_NP administration_NN ._SENT However_RB ,_, because_IN HSS_NP reduces_VBZ but_CC does_VBZ not_RB completely_RB abrogate_VB proinflammatory_JJ pathways_NNS ,_, there_EX is_VBZ an_DT adequate_JJ balance_NN between_IN proinflammatory_JJ and_CC anti-inflammatory_JJ cytokines_NNS ,_, thus_RB maintaining_VBG the_DT ability_NN to_TO fight_VB bacteria_NNS efficiently_RB ._SENT The_DT potential_JJ beneficial_JJ effect_NN of_IN small_JJ volume_NN resuscitation_NN with_IN HSS_NP ,_, which_WDT has_VBZ been_VBN extensively_RB studied_VBN in_IN hypovolemic_JJ shock_NN ,_, appears_VBZ to_TO be_VB reproducible_JJ in_IN various_JJ models_NNS of_IN experimental_JJ septic_JJ shock_NN ._SENT The_DT anti-inflammatory_JJ effects_NNS of_IN hypertonic_JJ saline_NN on_IN neutrophils_NNS ,_, oxidative_JJ burst_NN ,_, and_CC cytokine_NN release_NN are_VBP mediated_VBN through_IN the_DT signaling_VBG molecule_NN MAPK_NN p38_NN ._SENT These_DT effects_NNS may_MD reduce_VB the_DT excessive_JJ proinflammatory_JJ action_NN found_VBN in_IN sepsis_NN ,_, reducing_VBG the_DT degree_NN of_IN damage_NN to_TO multiple_JJ organs_NNS ._SENT Hemodynamic_JJ effects_NNS have_VBP been_VBN widely_RB demonstrated_VBN ,_, and_CC recent_JJ data_NNS showed_VBD that_IN early_JJ goal-directed_JJ therapy_NN is_VBZ very_RB important_JJ in_IN reducing_VBG mortality_NN ._SENT The_DT vicious_JJ circle_NN of_IN ischemia_NN ,_, inflammation_NN ,_, fluid_JJ extravasation_NN ,_, and_CC ischemia_NN that_WDT occurs_VBZ in_IN sepsis_NN may_MD perpetuate_VB damage_NN to_TO organs_NNS ._SENT A_DT therapy_NN that_WDT simultaneously_RB blocks_VBZ both_DT of_IN the_DT damaging_JJ components_NNS of_IN sepsis_NN ,_, namely_RB ischemia_NN and_CC inflammation_NN ,_, will_MD probably_RB have_VB an_DT enormous_JJ impact_NN on_IN our_PP$ ability_NN to_TO manage_VB this_DT condition_NN ._SENT HSS_NP is_VBZ emerging_VBG as_IN a_DT possible_JJ preventive_NN therapeutic_JJ in_IN sepsis_NN ._SENT None_NN declared_VBD ._SENT HOG_NN =_SYM high-osmolarity_NN glycerol_NN response_NN ;_: HSS_NP =_SYM hypertonic_JJ saline_JJ solution_NN ;_: MAPK_NP =_SYM mitogen-activated_JJ protein_NN kinase_NN ._SENT 